SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-037804
Filing Date
2020-08-06
Accepted
2020-08-06 16:31:03
Documents
59
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q prnb-10q_20200630.htm   iXBRL 10-Q 2732715
2 EX-31.1 prnb-ex311_6.htm EX-31.1 20045
3 EX-31.2 prnb-ex312_8.htm EX-31.2 20085
4 EX-32.1 prnb-ex321_7.htm EX-32.1 16240
  Complete submission text file 0001564590-20-037804.txt   8729877

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA prnb-20200630.xsd EX-101.SCH 41360
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prnb-20200630_cal.xml EX-101.CAL 46069
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prnb-20200630_def.xml EX-101.DEF 129093
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE prnb-20200630_lab.xml EX-101.LAB 354260
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prnb-20200630_pre.xml EX-101.PRE 261332
10 EXTRACTED XBRL INSTANCE DOCUMENT prnb-10q_20200630_htm.xml XML 1805782
Mailing Address 220 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 220 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Filer) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38653 | Film No.: 201082185
SIC: 2834 Pharmaceutical Preparations